Sign up to see all 5.
None.
Sign up to see all 4.
Every notice on Red Flags →A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.
There are not yet two fiscal years of reported share counts for Alamar Biosciences Inc.
| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
SC
Sands Capital Alternatives, LLC
13D · 6.1%
|
4.2M | 6.10% | NEW | Q2 '26 | 18.7% | |
|
Shares held by quarter
Peak holding4.2M (Q2'26)
Change over 8 quarters+4.2M
Share of the company6.100%
Disclosed stake13D · 6.1%
|
||||||
|
SB
Samsara Biocapital, LLC
|
2.5M | 3.57% | NEW | Q2 '26 | 5.5% | |
|
Shares held by quarter
Peak holding2.5M (Q2'26)
Change over 8 quarters+2.5M
Share of the company3.570%
|
||||||
23 more super investors behind a free account
See every manager holding Alamar Biosciences Inc, how their position has changed, and how long they've held it.
Sign up free| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
AG
ARK ETF Trust
|
$24.3M | 957.2K | 1.38% | 1.56% | July 31, 2026 |
|
AV
ARK Venture Fund
ARK Venture Fund
|
$16.9M | 667.7K | 0.96% | 1.43% | July 31, 2026 |
23 more funds behind a free account
See every fund holding Alamar Biosciences Inc and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
NN
Nicholas Naclerio
5%+ holder
13D · 9.6%
|
6.4M | 9.17% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
II
Illumina Innovation Fund II, L.P.
5%+ holder
13D · 8.8%
|
5.9M | 8.44% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of Alamar Biosciences Inc.
Sign up freeLoading...